Originally published In Press as doi:10.1074/jbc.M112003200 on March 28, 2002
J. Biol. Chem., Vol. 277, Issue 23, 20724-20733, June 7, 2002
Activation of Maf/AP-1 Repressor Bach2 by Oxidative Stress
Promotes Apoptosis and Its Interaction with Promyelocytic
Leukemia Nuclear Bodies*
Akihiko
Muto
§,
Satoshi
Tashiro
,
Haruka
Tsuchiya
,
Akihiro
Kume¶,
Masamoto
Kanno
,
Etsuro
Ito**,
Masayuki
Yamamoto
, and
Kazuhiko
Igarashi
§§
From the
Department of Biochemistry, Hiroshima
University School of Medicine, Hiroshima 734-8551, Japan, the
¶ Division of Genetic Therapeutics, Center for Molecular Medicine,
Jichi Medical School, Tochigi 329-0498, Japan, the
Department of Immunology, Hiroshima University School of
Medicine, Hiroshima 734-8551, Japan, the ** Department of
Pediatrics, Hirosaki University School of Medicine, Hirosaki 036-8563, Japan, and the 
Center for Tsukuba Advanced
Research Alliance and Institute of Basic Medicine, University of
Tsukuba, Tsukuba 305-8575, Japan
Received for publication, December 17, 2001, and in revised form, March 12, 2002
 |
ABSTRACT |
The oxidative stress response operates by
inducing the expression of genes that counteract the stress. We show
here that the oxidative stress-responsive transcription factor Bach2 is
a generic inhibitor of gene expression directed by the
12-O-tetradecanoylphorbol-13-acetate response
element, the Maf recognition element, and the antioxidant-responsive element. The Bach2-enhanced green fluorescent protein bicistronic retrovirus was used to monitor the fate of Bach2-expressing cells at
the single cell level. Bach2 exerted an inhibitory effect on NIH3T3
cell proliferation and caused massive apoptosis upon mild oxidative
stress in both NIH3T3 and Raji B-lymphoid cells. Interestingly, Bach1,
a highly homologous protein, could not induce cell death, demonstrating
the specificity for the apoptosis induction. Although both oxidative
stress and leptomycin B, an inhibitor of nuclear export, induce nuclear
accumulation of Bach2, the leptomycin B-induced nuclear accumulation of
Bach2 was not sufficient to elicit apoptosis. Upon oxidative stress,
Bach2 formed nuclear foci that associated with promyelocytic leukemia
nuclear bodies. Our results suggest that Bach2 constitutes a cell
lineage-specific system that couples oxidative stress and cell death
and that inhibition of 12-O-tetradecanoylphorbol-13-acetate response element, the Maf recognition element, and the
antioxidant-responsive element upon oxidative stress may be critical
determinants for apoptosis.
 |
INTRODUCTION |
Oxidative stress is characterized by high cellular levels of
reactive oxygen species
(ROS)1 that have damaging
effects on cellular components and so trigger defensive responses by
the cell. In addition, ROS have been shown to act as intracellular
second messengers for certain cytokines and growth factors (1-3).
Several observations suggest that ROS may mediate apoptosis. Apoptosis
also appears to be induced by p53 in part by the transcriptional
induction of redox-related genes that supposedly lead to increased
levels of ROS (4). Although the importance of ROS in the execution of
apoptosis is still controversial, they are likely to be involved as
second messengers in the apoptotic signal transduction pathway. For
example, apoptosis signal-regulating kinase 1 is activated by
hydrogen peroxide to induce apoptosis (5). However, the specific
molecular targets of ROS in apoptosis signaling are still largely
unknown, leaving the mechanisms responsible for ROS-induced cell death unclear. We show here that the transcription repressor Bach2 induces cell death upon oxidative stress.
The dimeric AP-1 transcription factor complexes control cell
proliferation, differentiation, and apoptosis by regulating gene expression upon exposure to various stimuli (6). Originally, four
different subclasses of basic leucine zipper (bZip) dimers were
identified (i.e. AP-1, ATF/cAMP response element-binding protein, CCAAT/enhancer-binding protein, and Maf) based upon the DNA sequences they bind (7). Dimers of the oncoprotein, v-Maf, and its
related factors bind to Maf recognition elements or MARE (8, 9).
Because MARE embeds a 12-O-tetradecanoylphorbol-13-acetate (TPA) response element (TRE), it is also a binding site for the Jun and
Fos family members (8). In addition, the small Maf proteins
(i.e. MafF, MafG, and MafK) bind to versions of MARE and
activate transcription by forming heterodimers with the CNC (Cap'n'Color) family of bZip proteins including the hematopoietic transcription factor NF-E2 p45 and its related factors Nrf1,
Nrf2, and Nrf3 (10-15).
In a yin-yang scenario typical in biological systems, transcription
activators are often opposed by repressors that target the same DNA
elements. This is also the case for the Maf-CNC system. Like NF-E2 p45
and others, Bach1 and Bach2 form heterodimers with the small Maf
proteins to bind to MARE. However, the resulting heterodimers repress
MARE-dependent transcription (16). Furthermore, homodimers
of the small Maf and small Maf/Fos heterodimers also function as
repressors (9, 17, 18). Thus, there appears to be a complex
transcriptional antagonism regulating MARE-dependent gene
expression and its cross-talk with the TRE-dependent
system. The presence of a vast number of combinations of MARE-binding factors, including those both positive and negative, suggests that MARE
is involved in various biological processes and that deregulation of
MARE-mediated gene expression underlies cell transformation by Maf and
AP-1 oncoproteins. One clue to understanding the biological function of
MARE is its close resemblance to the antioxidant-responsive element,
ARE.
Cells protect themselves against ROS with various defensive mechanisms
including compounds such as glutathione and metallothioneins and
detoxifying enzymes like glutathione S-transferase and heme oxygenase 1. The inducible expression of these genes is mediated at
least in part by ARE. When compared with other AP-1-binding DNA
sequences, ARE is related most closely to MARE (8, 19-21). Conversely,
MARE confers oxidative stress inducibility upon reporter genes in
transfection assays, suggesting that MARE is endowed with an ARE-like
activity (22, 23). In vitro, ARE is bound by various
AP-1-related transcription factors. Gene targeting experiments have
shown that Nrf1 and Nrf2 play important roles in the inducible
expression of genes with ARE (24-27).
Oxidative stress regulates subcellular localization of Bach2 through an
oxidative stress-sensitive conditional nuclear export (23), suggesting
a role for Bach2 as a biological switch that processes and transduces
oxidative stress into the nucleus. In cultured cells, Bach2 is
localized in the cytoplasm through its C-terminal evolutionarily
conserved cytoplasmic localization signal (CLS). The CLS directs
leptomycin B-sensitive and Crm1/Exportin1-dependent nuclear
export. However, CLS is distinct from the conventional leucine-rich
class of nuclear export signal in that oxidative stress aborts the CLS
activity and induces nuclear accumulation of Bach2 (23). Regulation of
transcription factor localization is a key aspect of many signal
transduction pathways. Considering its regulation, Bach2 appears to
play an important role in the oxidative stress response in mammalian
cells. To understand the biological function of Bach2 in the oxidative
stress response, we first asked whether Bach2 is a specific repressor
of MARE or a generic repressor of TRE, MARE, and ARE. We carried out
Bach2 overexpression studies and examined its effect and dynamics at the level of a single cell during oxidative stress. Finally, we show
dynamic interaction of Bach2 with promyelocytic leukemia (PML) nuclear bodies.
 |
MATERIALS AND METHODS |
Plasmids--
Retroviral vectors were constructed using the
MSCV/IRES-EGFP vector. FLAG epitope-tagged Bach2, Bach2
BTB,
Bach2
Zip, and Bach1 cDNAs were constructed as follows. An
expression plasmid pcDNA3.1FLAG for FLAG fusion proteins was
constructed by inserting FLAG-coding cDNA between the
NotI and BamHI sites of pcDNA3.1B (Invitrogen). The FLAG cDNA was
5'-GGCGGCCGCTCTAGACCATGGACTACAAGGACGACGATGACAAGGGATCC-3' (the NotI and BamHI sites are underlined). An
entire open reading frame of mouse Bach2 cDNA (16) was isolated by
PCR and inserted into the BamHI site of pcDNA3.1BFLAG,
resulting in pcDNAFLAGBach2. The primers possessing
BamHI site at each 5' end, were
5'-GTTAAGGATCCATGTCTGTGGATGAGAGACCT-3' and
5'-GTTAAGGATCCCTAGGCATAATCTTTCCTGGG-3' (initiation and stop codons are underlined). A 2.5-kilobase pair NotI and
HindIII fragment was isolated from the pcDNAFLAGBach2,
filled in, and inserted into the HpaI site of MSCV/IRES-EGFP
(28). To construct Bach2
BTBFLAG, the
EcoRI-BamHI fragment was isolated from Bach2
cDNA, filled in, and cloned into the blunt-ended KpnI
site of pcDNA3.1FLAG, resulting in pF-
BTBB2. A filled-in
NotI and HindIII fragment of pF-
BTBB2 was
cloned into the HpaI site of MSCV/IRES-EGFP. To construct
the Bach2
Zip retrovirus vector, NotI and PmeI
fragments were isolated from the Bach2
Zip expression vector (29),
filled in, and cloned into the HpaI site of MSCV/IRES-EGFP.
The PCR-created mouse Bach1 cDNA fragment (16) was inserted into
the BamHI and HindIII site of pcDNA3.1FLAG,
generating pF-Bach1. The primers (5'-GTTAAGAATGATCAATGTCTGTGAGTGAGAGT-3' and
5'-GTTAAGAAGCTTTTACTCGTCAGTAGTGCACTT-3') contained the
BclI and HindIII sites, respectively, and were
amplified between the initiation and stop codons of Bach1. A
2.5-kilobase pair filled-in NotI and HindIII
fragment of pF-Bach1 was inserted into the HpaI site of
MSCV/IRES-EGFP.
To generate chimeric cDNAs of Bach1 and Bach2, portions of the
respective cDNAs were isolated by PCR and ligated into
pcDNA3.1BFLAG. The primers used to generate B1B2A were:
5'-GTTAAGAATGATCAATGTCTGTGAGTGAGAGT-3' and
5'-GCAGCAGGTACCCAGGCTAATCACACAAGC-3' containing the BclI and KpnI sites, respectively (for Bach1 amplification)
and 5'-GCAGCAGGTACCAATTCCAGTGACGAGTCT-3' and
5'-GCAGCAAAGCTTCTAGGCATAATCTTTCCT-3' containing the KpnI and HindIII sites, respectively (for Bach2). Amplified DNA were
digested with BclI and KpnI or KpnI
and HindIII and were inserted between the BamHI
and HindIII sites of pcDNA3.1BFLAG, resulting in
pcDNAFLAGB1B2(A). The primers used to generate B2B1B were:
5'-GTTAAGGATCCATGTCTGTGGATGAGAAGCCT-3' and
5'-GCAGCAGGATCCGTAAGACTGCTCACATTT-3' containing the BamHI site (for Bach2) and 5'-GCAGCAGGATCCGACTCTGAGACGGACACG-3' and 5'-GTTAAGAAGCTTTTACTCGTCAGTAGTGCACTT-3' containing the BamHI
and HindIII sites, respectively (for Bach1). Amplified DNA
were digested with BamHI or BamHI and
HindIII and were inserted between the BamHI and
HindIII sites of pcDNA3.1BFLAG, resulting in
pcDNAFLAGB2B1(B). pcDNAFLAGB1B2(C) was constructed by
substituting the EcoRI-HindIII fragment of
pcDNAFLAGB1B2(A) with a Bach2 cDNA amplified with a primer set
of 5'-GCAGCAGAATTCGAAGAGGAGGAAGAAGAG-3' and
5'-GCAGCAAAGCTTCTAGGCATAATCTTTCCT-3' containing EcoRI
and HindIII sites, respectively. To generate retrovirus
vectors, NotI-HindIII DNAs were isolated from
these chimeric cDNA plasmids and bluntly inserted into the
HpaI site of the MSCV/IRES-EGFP vector.
Transfection Reporter Assays--
The reporter plasmids are
based on a TATA box-luciferase reporter plasmid and were described
previously (8, 12, 30). The MARE reporter 1 possesses three copies of
the palindromic MARE, whereas reporter 23 possesses mutated MARE,
retaining functional TRE, and thus allows binding of Jun/Fos dimers but
not Maf dimers (8). The ARE reporter was described previously (30).
Transfection reporter assays were carried out as described previously
(23). Three independent experiments, carried out in duplicate, were performed, and the results are averaged and diagrammed with the standard errors.
Cell Culture--
Phoenix Ecotropic packaging cells were
provided by Dr. G. P. Nolan. The packaging cells and NIH3T3 cells
were cultured in Dulbecco's modified Eagle's medium (Nissui) with
10% fetal bovine serum (JRH BioSciences), 100 units/ml penicillin, and
100 µg/ml streptomycin (Invitrogen). Bach2-overexpressing and control
Raji clones were described previously (31). The cells were treated with
diethyl maleate (DEM) or H2O2 (WAKO-jyunyaku)
at the indicated concentrations.
Transduction of NIH3T3 Cells--
Phenix Ecotropic packaging
cells were transfected with each retroviral vector construct using
FuGENE 6 Transfection Reagent (Roche Molecular Biochemicals), and the
viral supernatants were harvested 2 days after transfection. For
infection, retroviral-containing supernatants with 4 µg/ml Polybrane
were added to NIH3T3 cells. After 3 h of incubation in a 5%
CO2 incubator, fresh culture medium was added. Two days
post infection, infected NIH3T3 cells were harvested and passaged.
Immunoblotting Analysis--
Whole cell extracts were prepared
from transduced NIH3T3 cells or transfected QT6 cells, separated on
7.5% SDS-polyacrylamide gels, transferred onto polyvinylidene
difluoride membranes (Millipore), and processed for reaction with
antibodies as described previously (29). All of the antibody reactions
were performed in Tris-buffered saline (0.15 M NaCl, 20 mM Tris-HCl, pH 7.5) with 5% skim milk and 0.05% Tween
20. Detection of peroxidase activity was performed with an ECL system
(Amersham Biosciences).
FACS Analysis--
NIH3T3 cells were collected using
Trypsin-EDTA (Sigma) treatment, and the cells were stained with 2.5 µg/ml propidium iodide (Sigma) in PBS. The cells were sorted using a
fluorescence cell sorter (FACScalibur; Becton Dickinson). The collected
data were analyzed by CellQuest software (Becton Dickinson).
Immunofluorescence Staining--
To detect the cell surface
phospholipid phosphatidylserine, NIH3T3 cells were stained with
phycoerythrin-conjugated annexin V (PharMingen) in annexin binding
buffer (PharMingen) for 15 min at room temperature without any
fixation. Transfected 293T cells were fixed with 4% paraformaldehyde
in 1× PBS. Thereafter cells were permeablized with 0.1% SDS, 0.5%
Triton X-100, PBS for 10 min. For the detection of PML and Bach2, fixed
cells were incubated with rabbit anti-Bach2 antiserum (F69-2; Ref.16)
and mouse anti-PML (Santa Cruz) diluted at 1:500 and 1:200,
respectively, in 1% bovine serum albumin, 1× PBS. Cy3-conjugated
sheep anti-mouse (Jackson ImmunoResearch Lab.), fluorescein
isothiocyanate-conjugated goat anti-rabbit (Tago), and Cy3-conjugated
sheep anti-rabbit (Jackson ImmunoResearch Laboratory), diluted in 1%
bovine serum albumin, 1× PBS, were used as secondary antibodies. All
of the antibody incubations were performed at 37 °C for 30 min. The
nuclei were stained with 10 µM Hoechst 33342.
Image Acquisition--
The images were taken with a Leica
epifluorescence microscope equipped with a charge-coupled device camera
controlled by QFluoro software (Leica). Adobe Photoshop was used for
presentation of the images.
 |
RESULTS |
Effects of Bach2 on the Related Enhancers TRE, MARE, and
ARE--
To understand the repertoires of genes that are regulated by
Bach2, we first examined the effects of Bach2 upon TRE, MARE, or ARE
reporters in co-transfection assays using NIH3T3 cells (Fig.
1). Bach2 repressed
MARE-dependent reporter gene expression (palindromic MARE
reporter 1 and NF-E2-type MARE from the chicken
-globin gene) as
well as the TRE reporter (reporter 23). In addition, the ARE reporter
that possesses three copies of ARE of GST-Ya gene (30) was also
efficiently inhibited. In contrast, Bach2 had no effect on the reporter
plasmid carrying mutated MARE sequences (reporter 17), verifying its
sequence specificity. The oxidative stressor DEM that depletes
glutathione induced MARE- and ARE-dependent expression but
not TRE-dependent expression, suggesting a functional distinction among the related enhancers. Co-expression of Bach2 efficiently inhibited the induction of MARE and ARE by DEM. These results indicate that Bach2 inhibits the related enhancers TRE, MARE,
and ARE as well as the induction of the latter two elements upon
oxidative stress. Bach2 most likely binds to MARE and ARE along with
the small Maf protein in transfected cells (16). On the other hand,
because Bach2 binds to TRE as a homodimer in vitro (16), its
homodimer may repress TRE.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 1.
Bach2 represses TRE-related enhancers.
A, comparison of sequences inserted into luciferase reporter
plasmids: NF-E2-type MARE from -globin gene, palindromic MARE
(reporter 1), ARE from GST-Ya gene, TRE (reporter 23), and mutated MARE
(reporter 17) that does not bind AP-1 or Maf. B, NIH3T3
cells were transfected with the indicated luciferase reporter gene
plasmids with or without the Bach2 expression plasmid. Where indicated,
the cells were treated with 150 µM DEM for 24 h
before conducting the luciferase assays. The results are reported as
the means of three transfections carried out in duplicate.
|
|
Expression of Bach2 and Bach1--
The above results suggest Bach2
as a generic inhibitor of TRE-related enhancers. To evaluate the effect
of Bach2 expression on cellular function at the level of a single cell,
we employed a bicistronic retroviral system possessing the
encephalomyocarditis virus-derived IRES and the EGFP with a murine stem
cell virus backbone (28). Virus-infected cells can be monitored
individually without selecting clonal stable cell lines. This is
important when one is to analyze the effects of toxic gene products.
The structures of retroviral vectors used in this study are depicted in
Fig. 2A. The wild-type Bach2
cDNA and its derivatives were placed upstream of the IRES-EGFP.
Some of the cDNAs were tagged with a FLAG epitope-coding sequence
to monitor their expression. Bach2
BTB lacked the BTB domain
that is specific to Bach1 and Bach2 among the NF-E2-related factors.
The BTB (Broad-Complex, Tramtrack, and Bric-a-brac) domain is found in
more than 100 human proteins (32) and mediates oligomer formation
(33-36), DNA loop generation (37), and nuclear foci formation (34, 35,
38). Bach2
Zip lacked the leucine zipper region that mediates
dimerization with small Maf family factors and is thus essential for
DNA binding. To compare their biological functions, we also constructed
a FLAG-Bach1 retrovirus. To verify their expression, we prepared
extracts from infected NIH3T3 cells and performed immunoblot analyses
using an anti-Bach2 monoclonal antibody (Fig. 2B) or
anti-FLAG antibody (Fig. 2C and see below). The epitope of
the anti-Bach2 antibody resides just upstream of the basic
region.2 The retroviruses
expressed antigens of expected sizes and at similar levels (Fig.
2B).

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 2.
Retrovirus system expressing Bach2 and Bach1.
A, construction of retroviral vectors is depicted. The
numbers indicate the positions of deletion junctions on the
amino acid sequence of Bach2. B, whole cell extracts were
prepared from NIH3T3 cells infected with retroviruses without cDNA
(lane 1) or with Bach2 cDNAs (lanes 2-4).
Expression of Bach2 and its derivatives was analyzed by immunoblotting
with the Bach2 monoclonal antibody. C, Bach1 and Bach2
retroviral vectors were transfected into QT6 cells. One day after
transfection, whole cell extracts were prepared from each culture.
Immunoblotting analysis was performed with the anti-FLAG
antibody.
|
|
Negative Regulation of Cell Proliferation by Bach2--
Activation
of TRE- and MARE-dependent transcription appears to lead to
transformation (8, 39-43). Because Bach2 represses both TRE- and
MARE-dependent transcription, it is possible that Bach2 is
a negative regulator of cell proliferation. To test this possibility,
we infected NIH3T3 cells with the retroviruses and monitored changes in
the relative numbers of infected and uninfected cells (i.e.
EGFP-positive and -negative cells) in each cell culture using a FACS.
Four days after infection, more than 50% of the cells were
EGFP-positive. Thereafter, levels of Bach2-expressing cells were
remarkably reduced as determined by the ratios of EGFP-positive cells
(Fig. 3A). Diminution of
Bach2-expressing cells was very rapid, and the numbers were reduced to
1.6% by day 14 post-infection (Fig. 3B). The disappearance
of Bach2-expressing cells was confirmed by immunoblot analyses of cell
extracts with the anti-Bach2 antiserum (Fig. 3C). Four days
after infection, the cells expressed Bach2 abundantly. However, by day
12 post-infection, there were no detectable levels of Bach2 being
expressed. The relative numbers of Bach2
BTB-expressing cells also
decreased after infection. However, the kinetics for reduction was
slower than that for cells expressing the full-length Bach2 (Fig.
3B). In addition, a significant fraction of cells was still
EGFP-positive at 14 days post-infection. The ratios of
Bach2
Zip-expressing cells did not change (Fig. 3, A and
B). Because these Bach2 derivatives are expressed at similar
levels (Fig. 2B), the differences in their inhibitory
effects on cell proliferation could not be explained by a different
expression level of each construct. Even though Bach1 and Bach2 share
many biochemical activities, we could not detect any obvious effect of
Bach1 on cell proliferation (Fig. 3B). The levels of Bach1 and Bach2 accumulation were compared by immunoblot analysis using an
anti-FLAG antibody (Fig. 2C). Even though the band
corresponding to Bach1 migrated to a position equal to that of an
endogenous reactive band with an unknown identity, it is clearly shown
that Bach1 is expressed at higher levels than Bach2 in this system. These results indicate that Bach2 possesses an inhibitory or toxic effect on cell proliferation and that the DNA binding activity of Bach2
is a prerequisite for the effect. Furthermore, the results obtained
with the Bach2
BTB retrovirus suggest a critical role for the BTB
domain in the regulation of cell proliferation. Most surprisingly,
Bach1 does not possess the ability to inhibit cell proliferation when
expressed in NIH3T3 cells. The possibility that the Bach2-IRES-EGFP
transgene underwent selective silencing is unlikely based on the
observations described below.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 3.
Bach2 negatively regulates cell
proliferation. A, NIH3T3 cells were infected with
various retroviruses and maintained by passaging cells every 2 days. At
4 and 14 days after infection, viable 1 × 104 cells
were analyzed for EGFP fluorescence by flow cytometry. Histograms show
EGFP-positive infected cells (shaded) and EGFP-negative
uninfected cells (solid line). B, ratios of
EGFP-positive cells were determined at indicated days after infection
of viruses containing indicated transgenes. The results are the average
of two or three independent infections. C, expression levels
of Bach2 were compared by immunoblotting whole cell extracts prepared
from cultures at 4 and 12 day post infection using anti-Bach2 antiserum
(upper panel). Equal protein loading was verified by
reacting the same blot under conditions that allow multiple nonspecific
binding (lower panel).
|
|
Bach2 Enhances Oxidative Stress-induced Cell Death--
To
elucidate the biological role of Bach2 during oxidative stress, we
examined the fate of Bach2-overexpressing cells upon exposure to
oxidative stress. Three days after infection, transduced NIH3T3 cells
were treated with 50 or 150 µM DEM. After further incubating for 24 h, the cells were stained with propidium iodide (PI), and the numbers of living cells and PI-stained dead cells were
measured by FACS. Roughly 45-70% of the cells were EGFP-positive at
the beginning of the DEM treatment. After 1 day of incubation, we
observed a significant reduction in the number of EGFP-positive cells
in the cultures infected with the wild-type Bach2 virus (Fig.
4A). In contrast, we observed
virtually no effect of DEM treatment in the cultures infected with the
EGFP virus. Even though Bach2
BTB-overexpressing cultures exhibited a
decrease in EGFP-positive cells, there were significant numbers of
surviving cells that were EGFP-positive. Overall, we did not observe
any change in the numbers of EGFP-positive cells in the cultures
infected with the Bach2
Zip virus (Fig. 4A). The
percentages of PI-positive dead cells in all of the cultures are shown
in Fig. 4B. These results clearly indicate that Bach2 caused
rapid cell death in the presence of oxidative stress and that the BTB
domain was not essential; however, it did play an auxiliary role in the
cell death-inducing activity of Bach2. The data obtained with
Bach2
Zip clearly show that the DNA binding activity of Bach2 is
indispensable for the response to oxidative stress.

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 4.
Expression of Bach2 enhances sensitivity to
oxidative stress. Three days after infection with the indicated
viruses, each culture of NIH3T3 cells was treated with 50 or 150 µM DEM. After 24 h, the cells were stained with PI
to determine levels of dead cells by flow cytometry. A,
histograms show EGFP properties of PI-negative living 1 × 104 cells; EGFP-positive infected cells (shaded)
and EGFP-negative uninfected cells (solid line).
B, bar graph shows the percentages of PI-positive
dead cells. The results are reported as the means ± S.E. of three
independent experiments.
|
|
In addition to DEM, hydrogen peroxide caused a massive and selective
death of Bach2-overexpressing cells (Fig.
5A). In contrast to Bach2,
however, the expression of Bach1 did not enhance the induction of cell
death upon treatment with DEM or hydrogen peroxide, indicating a
functional distinction between the related factors. Amounts of Bach1
within cells were not affected by the hydrogen peroxide treatment (Fig.
5B), excluding the possibility that oxidative stress
decreased Bach1 protein levels. These observations establish a
biological role for Bach2 in the oxidative stress response by its
enhancement of cell death.

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 5.
Oxidative stress but not leptomycin B induces
cell death in the presence of Bach2. Three days after infection of
NIH3T3 cells with the control EGFP, Bach2, or Bach1 viruses, the
cultures were treated with the indicated concentrations of DEM or
hydrogen peroxide (A) or DEM or leptomycin B (C),
for 24 h. The cells were stained with PI to determine levels of
dead cells by flow cytometry. The results are the averages of two
independent experiments. Variations between samples were less than 5%.
B, 293T cells were transfected with Bach1 expression plasmid
(lanes 2-4) and were treated with hydrogen peroxide (0, 100, or 200 µM) for 24 h. The amounts of Bach1 were
determined by immunoblotting analysis with anti-Bach1 antiserum.
D, NIH3T3 cells infected with the Bach2 virus were left
untreated or treated with LMB and were stained with the anti-Bach2
antiserum (right panels). The arrowheads indicate
specific signals. DNA was stained with Hochest33342 (left
panels).
|
|
Nuclear Accumulation of Bach2 Is Not Sufficient for Cell
Death--
Because oxidative stress induces the nuclear accumulation
of Bach2, this alone may be sufficient to induce cell death.
Alternatively, Bach2 may cooperate with other regulators that are also
activated by the stress. To address these possibilities, we examined
the effects of leptomycin B (LMB), which inhibits the exporter protein Crm1 and thus induces the nuclear accumulation of Bach2 (23). NIH3T3
cells were infected with the Bach2-expressing retrovirus and cultured
in the absence or presence of LMB, and the number of PI-positive cells
were monitored as described above. In contrast to DEM, LMB did not
change the number of dead cells (Fig. 5C), which means that
the nuclear accumulation of Bach2 induced by LMB is not sufficient to
induce cell death. Nuclear accumulation of Bach2 in the presence of LMB
was confirmed by immunostaining of the infected cells (Fig.
5D). These results suggest that the activation of additional
signaling cascade(s) by oxidative stress is essential for causing cell
death in the presence of Bach2. Alternatively, LMB treatment per
se may protect cells from cell death. However, this is unlikely
because LMB was shown previously to promote apoptosis by the BCR-ABL
fusion gene product (44).
Bach2-dependent Cell Death Is Apoptotic--
To
examine whether oxidative stress-induced cell death in Bach2-expressing
cells occurs via an apoptotic mechanism, we monitored the cell surface
expression of the phospholipid, phosphatidylserine. NIH3T3 cells
infected with the Bach2 or control retroviruses were treated with 150 µM DEM for 10 h, and the cultures were stained using
phycoerythrin-conjugated annexin V. The cells were viewed under
fluorescent microscopy for the binding of annexin V-phycoerythrin. Annexin V binding was clearly detected in Bach2-expressing cells but
not in uninfected cells (i.e. EGFP-negative cells; Fig.
6A, left column).
In contrast, annexin V binding was not observed in cells infected with
the control EGFP virus (Fig 6A, right column). Although 40-50% of the Bach2-expressing cells were found positive for
annexin V binding, virtually no cell was positive in the control virus-infected cultures. To observe changes in nuclear morphology, the
cells were stained with Hoechst 33342 following treatment with DEM for
12 h. Nuclear condensations were observed only in the
EGFP-positive and, thus, Bach2-overexpressing cells (Fig. 6B). The cells infected with the control virus exhibited no
changes in nuclear morphology (data not shown). Taken together, these observations suggest that Bach2 induces cell death upon oxidative stress through an apoptotic pathway.

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 6.
Apoptotic Bach2-dependent cell
death. A, three days after infection of NIH3T3 cells with
the control EGFP (right panels) or Bach2 viruses (left
panels), the cultures were treated with 150 µM DEM
for 10 h. The cells were stained with phycoerythrin-conjugated
annexin V to detect cell surface expression of the phospholipid
phosphatidylserine. Merged, annexin V binding, EGFP expression, and
transmission images are shown. B, changes in nuclear
morphology during oxidative stress-induced cell death. NIH3T3
cells were infected with the Bach2 retrovirus, treated with 150 µM DEM for 12 h (lower panel) or left
untreated (upper panel), and stained with Hoechst 33342 to
observe nuclear morphology (left panels). Infected cells
were identified by EGFP fluorescence (middle panels). The
merged images are shown (right panels).
|
|
Bach2-induced Cell Death of B-lymphoma Cells--
The effect of
Bach2 on the control of cell death may vary depending on the cellular
context. Because Bach2 is expressed specifically in B-cells among
hematopoietic cells (29), we were interested in whether Bach2
influences the sensitivity to oxidative stress among the B-lineage
cells as well. Previously, we reported the establishment of Raji cell
clones that overexpress human BACH2 (31). These clones seemed useful
for examining the effects of Bach2 overexpression in B-cells because
Raji cells do not express an endogenous BACH2 (31). We compared the
sensitivities of two BACH2-overexpressing (clones 67 and 75) and
two control (pDL2 and pDL3) cell lines to DEM. After treating cells
with DEM for 10 h, the cells were stained with PI, and the
percentages of dead cells were measured by FACS (Fig.
7). The percentages of PI-stained dead
cells increased in BACH2-expressing clones depending on the concentrations of DEM. In contrast, no significant increase in the
number of dead cells was observed in the two control cell lines. These
data suggest that expression of Bach2 increases the susceptibility of
B-cells to oxidative stress as well. Taken together, these results
suggest that one of the biological functions for Bach2 is in setting a
threshold for cell death induced by oxidative stress.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 7.
Bach 2 induces death of B-lymphoma
cells. Bach2-overexpressing (clones 67 and 75) and control
(pDL2 and pDL3) Raji clones were seeded (1 × 106
cells/ml) into 24-well plates and treated with DEM for 10 h. After
the treatment, the cells were stained with PI and analyzed by flow
cytometry. A, histograms show PI properties of 1 × 104 cells analyzed. B, percentages of
PI-positive dead cells with or without treatment with DEM were
determined. The data shown here are the means of three independent
experiments.
|
|
The N-terminal Region of Bach2 Specifies Pro-apoptotic
Function--
The above results indicate that Bach2 but not Bach1
functions as a pro-apoptotic factor activated upon oxidative stress.
This raises an interesting question regarding a functional distinction between Bach1 and Bach2 because both repress MARE-dependent
gene expression in transfection assays (16). Because the bZip domain determines the specificity of dimer formation and target gene selection, whereas the BTB domain mediates protein-protein
interactions, we asked whether or not these domains of Bach1 and Bach2
are functionally equivalent. To this end, we replaced the N- or
C-terminal regions of Bach2 with the corresponding regions of Bach1
(Fig. 8A). As shown in Fig.
8B, the chimeric proteins were expressed at similar levels
within transfected cells. NIH3T3 cells were infected with retroviruses
and treated with DEM, and the extent of cell death was compared (Fig.
8C). Among the chimeric proteins, the one containing the
Bach1 bZip domain (B2B1B) elicited an efficient induction of cell
death. On the other hand, the chimeric proteins containing the Bach1
N-terminal region (B1B2A) or the Bach1 BTB domain (B1B2C) resulted in a
significantly reduced efficiency in the induction of cell death. These
results indicate that the bZip domains of Bach1 and Bach2 function
similarly in the inducible cell death assay. Rather, the functional
specificity of Bach2 in terms of its cell death-inducing activity
resides within its N-terminal region, which includes the BTB
domain.

View larger version (36K):
[in this window]
[in a new window]
|
Fig. 8.
Pro-apoptotic function is specified by the
N-terminal region of Bach2. A, schematic represents chimeric
proteins. Percentages of amino acid identity between subregions are
shown between Bach1 and Bach2. For details, see "Materials and
Methods." B, QT6 cells were transfected with the indicated
expression plasmids, and the expression of chimeric and wild-type
proteins was examined by immunoblot analysis using the anti-FLAG
antibody. Specific bands are indicated with dots.
C, NIH3T3 cells were infected with retroviruses carrying the
indicated cDNAs or the control virus and treated with 150 µM DEM for 24 h, and the fractions of dead cells
were determined by PI staining as in Fig. 4. Efficiencies of cell death
induction of chimeric proteins were compared relative to that of
wild-type Bach2. The results are the means ± S.E. of three
independent experiments.
|
|
Bach2 Interaction with PML Nuclear Bodies--
Proteins with the
BTB/POZ (Poxvirus and zinc finger) domain are known to form
nuclear domains (45). These domains may represent the accumulation of
molecules into specific regulatory and/or functional sites within the
nucleus. One of the well characterized nuclear foci is nuclear bodies
(NBs) consisting of PML gene product (46, 47). Because PML is involved
in the regulation of apoptosis (48, 49), we examined the spatial
relationships of Bach2 with PML NBs upon oxidative stress. Human
embryonic kidney 293T cells were transfected with the Bach2 expression
plasmid and treated with DEM, and overexpressed Bach2 and endogenous
PML were detected by indirect immunofluorescence staining. As shown in
Fig. 9A, Bach2 showed a mainly
cytoplasmic localization, whereas PML was detected as clear dots within
nuclei in the absence of oxidative stress. Upon treating cells with
DEM, Bach2 translocated from the cytoplasm into nuclei, forming small
foci that were in close association with PML NBs (Fig. 9B).
By 2 h after the DEM treatment, about 70% of Bach2-positive cells
contained closely associated or co-localized Bach2 domains with PML NBs
(Fig. 9C and Table I). In
contrast, Bach2
BTB-expressing cells exhibited a constitutive nuclear
accumulation without any formation of nuclear dots both in the absence
or presence of DEM (Fig. 9D and data not shown). Consistently, we did not observe any nuclear foci with a GFP-Bach2 fusion protein lacking the BTB domain (23). These results indicate that
the BTB domain is important in regulating the subcellular localization
of Bach2 in two aspects. First, in the absence of oxidative stress, the
BTB domain is essential for the cytoplasmic localization of Bach2.
Second, in the presence of oxidative stress, it directs the spatial
interaction of the Bach2 foci with PML NBs.

View larger version (47K):
[in this window]
[in a new window]
|
Fig. 9.
Association of Bach2 with PML nuclear bodies
upon DEM treatment. Expression plasmids of Bach2 (A-C)
or Bach2 BTB (D) were transfected into 293T cells, and the
cells were then treated with 1 mM DEM for 0 h
(A and D), 1 h (B), or 2 h
(C). The cells were stained for PML and Bach2 proteins as
well as for DNA. Merged images show PML (red), Bach2
(green), and DNA (blue).
|
|
View this table:
[in this window]
[in a new window]
|
Table I
Cell count results for the subcellular localization of Bach2 and
Bach2 BTB
150 transfected cells were observed in each experiment and were
classified into four different categories: Cy. > Nuc., cytoplasmic
dominant staining; Nuc.-Diffuse, nuclear dominant staining and diffuse
distribution; Nuc.-PML ( ), nuclear dominant staining, Bach2 formed
foci and foci showed independent localization of PML NBs; Nuc.-PML (+),
nuclear dominant staining, Bach2 formed foci and the foci showed close
association with PML NBs.
|
|
 |
DISCUSSION |
The balance between cellular life and death is, in part, a
function of the ability of a cell to control oxidant insult (50). Because responses to oxidative stress vary in various cell lineages, there must be factors that modify the response of a cell to oxidative stress. Our results provide strong evidence that Bach2 can induce apoptosis in response to oxidative stress and may explain the fact that
different cells have different capacities to cope with oxidative
stress. In contrast, the related protein Bach1 does not appear to have
a similar function, indicating their functional specification. The
issue of whether this is likely to reflect a normal physiological
function of Bach2 or an artifact of overexpression needs to be
addressed using a loss of function approach and is now underway in our
laboratory. However, various properties of Bach2 as discussed below
strongly suggest its involvement in oxidative stress-induced cell death.
Involvement of Bach2 in oxidative stress-induced cell death is in
agreement with the inhibitory effect of Bach2 on ARE (Fig. 1). ARE has
been found to associate with oxidative stress-inducible genes such as
glutathione S-transferase, heme oxygenase-1, and peroxiredoxin (21, 51). In mice, Nrf2 functions as an activator of oxidative stress-inducible genes by binding to ARE (22, 26, 27, 51).
Considering the fact that Nrf2 and Bach2 regulate ARE in
opposite ways, the presence of Bach2 may inhibit the deployment of
protective responses against oxidative stress through ARE. Inhibition
of protective genetic mechanisms that guard against oxidative stress
probably plays an important role in the fate of the cell determining
survival and death. This model, which involves transcriptional
antagonism in the regulation of the ARE-dependent oxidative
stress response, can be extended to include the possibility that Bach2
induces apoptosis in a more direct manner such as the inhibition of
anti-apoptotic gene expression by ARE/MARE. Indeed, some of the
anti-apoptotic genes possess
MAREs.3 In addition to ARE,
we report for the first time that Bach2 also represses
TRE-dependent gene expression (Fig. 1). It has been suggested that AP-1 maintains a homeostatic function that reacts to
changes in environmental conditions to alter gene expression profiles
to adapt to new environments (6). Thus, inhibition of
TRE-dependent gene functions may be required for Bach2 to
regulate apoptosis. Because AP-1 has been implicated in apoptosis
(6), combinations of repression of ARE-, TRE-, and
MARE-dependent gene functions appear to underlie the rapid
and efficient apoptosis induced by oxidative stress.
On the other hand, however, we also show that although Bach1 does not
induce apoptosis, the bZip domains of Bach1 and Bach2 are
interchangeable in terms of apoptosis induction. This observation indicates that even though the DNA binding ability of Bach2 is a
necessary precondition for the induction of apoptosis, it is insufficient for inducing apoptosis. Rather, the N-terminal region, including the BTB domain, appears to specify the pro-apoptotic function
of Bach2. These observations suggest that even though both Bach1 and
Bach2 are evolutionarily related to each other and they both repress
transcription (16, 52), there is another level of regulation that
dictates Bach2-mediated cell death. Such a regulation most likely
depends upon the N-terminal region of Bach2. In this
respect, the association of the Bach2 foci with PML NBs
under conditions of oxidative stress is intriguing. NBs are nuclear
structures that contain a number of proteins including PML and are
disrupted in promyelocytic leukemia (46, 47, 53). PML has been shown to
exhibit growth-suppressive properties and to constitute a nuclear
signaling pathway for apoptosis (48, 49, 54). Given these findings, the
close association of Bach2 foci with NBs during oxidative stress may be
relevant to the role of Bach2 in the regulation of apoptosis. We
recently found that Bach1 does not form nuclear foci upon oxidative
stress.2 In further accord with this idea, although
Bach2
BTB exhibited constitutive nuclear localization, it failed to
form nuclear foci that associate with PML NBs and exhibited a reduced
efficacy in the inhibition of proliferation and the induction of
apoptosis upon oxidative stress. Furthermore, the substitution of the
N-terminal region of Bach2 with that of Bach1 (i.e. B1B2A;
Fig. 8) significantly reduced its activity. Thus, the requirement for
the Bach2-BTB domain and the adjacent region fits well with the
hypothesis that DNA binding alone is insufficient and that the
interaction of Bach2 with other molecules including NBs plays an
auxiliary role in regulating cell proliferation and apoptosis. A simple
model would be that the function of Bach2 is modulated by its
interaction with NBs. At present, however, we do not know which of the
NB proteins interacts directly with Bach2. Further analysis is required to clarify the role of Bach2 in its association with NBs and to determine the mechanism of NB-mediated apoptosis. Recently, it has been
reported that both PML and NBs are involved in the repression of
transcription (55, 56). It will be interesting to determine whether
TRE-, MARE-, and/or ARE-dependent gene expression in a chromatin environment is regulated by NBs.
Because the expression of Bach2 is specific to neural cells and B
lymphoid cells (16, 29), the pro-apoptotic function of Bach2 may be
important in these cells. Bach2 is abundantly expressed in the early
stages of B-cell differentiation and suppressed in terminally
differentiated plasma cells (29). Together with the expression profile
for Bach2, our findings raise the possibility that B lymphoid cells in
later stages of differentiation may be more resistant to oxidative
stress than cells in earlier stages that are expressing Bach2. Mature
B-cells migrate from lymphoid organs and target areas of inflammation.
In these areas reside oxidants generated by neutrophils and other
phagocytic cells (3). The absence of Bach2 in terminally differentiated
B-cells may allow for the induction of genes with ARE/MARE to cope with
oxidative stress. On the other hand, the presence of Bach2 in the early stages of differentiation may serve to sensitize cells to oxidative stress and/or other forms of stress, thus allowing for the effective elimination of cells during differentiation. Such a system may be
important as a quality control for B-cells during differentiation. The
involvement of Bach2 in apoptosis agrees with previous observations that Bach2 is a candidate tumor suppressor of B-cell lymphoma (31).
Further, inhibition of BCR/ABL kinase activity using STI571 in chronic
myeloid leukemia cell lines and CD34+ cells from chronic
myeloid leukemia patients during a lymphoid crisis, induces BACH2
expression (57). Because the most striking consequence of suppressing
BCR/ABL tyrosine kinase activity is the inhibition of proliferation and
subsequent induction of apoptosis (44, 58, 59), these observations also
imply a pro-apoptotic role for Bach2. The loss of Bach2 function may
predispose cells toward unlimited proliferation because such an event
would be expected to increase the threshold for oxidative
stress-induced cell death. Further studies of Bach2 will open a new
window into understanding the molecular connections between oxidative
stress, proliferation, differentiation, and cell death.
 |
ACKNOWLEDGEMENTS |
We thank Drs. Makoto Kobayashi and Hideto
Hoshino for stimulating discussions, Dr. Minoru Yoshida for providing
LMB, and Dr. Kosuke Kataoka for the MARE and ARE reporter plasmids. We
also thank Dr. G. P. Nolan for providing the Phoenix cell lines
and Dr. Naoko Minegishi for advice.
 |
FOOTNOTES |
*
This work was supported by grants-in-aid from the Ministry
of Education, Science, Sport and Culture and grants from
Yamanouchi Foundation for Research on Metabolic Disorders and the Naito
Foundation.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Supported by a Japanese Society for the Promotion of Science
Research Fellowship for Young Scientists.
§§
To whom correspondence should be addressed: Dept. of
Biochemistry, Hiroshima University School of Medicine, Kasumi
1-2-3, Hiroshima 734-8551, Japan. Tel.:
81-82-257-5135; Fax: 81-82-257-5139; E-mail:
igarak@hiroshima-u.ac.jp.
Published, JBC Papers in Press, March 28, 2002, DOI 10.1074/jbc.M112003200
2
A. Muto, S. Tashiro, and K. Igarashi,
unpublished observation.
3
E. Ito, unpublished observations.
 |
ABBREVIATIONS |
The abbreviations used are:
ROS, reactive oxygen
species;
ARE, antioxidant-responsive element;
DEM, diethyl maleate;
FACS, fluorescence activated cell sorter;
LMB, leptomycin B;
MARE, Maf
recognition element;
PI, propidium iodide;
TPA, 12-O-tetradecanoylphorbol-13-acetate;
TRE, TPA response
element;
EGFP, enhanced green fluorescent protein;
PML, promyelocytic
leukemia;
NB, nuclear body;
bZip, basic leucine zipper;
CLS, cytoplasmic localization signal;
PBS, phosphate-buffered saline;
IRES, internal ribosome entry site;
BTB, Broad-Complex, Tramtrack, and
Bric-a-brac.
 |
REFERENCES |
| 1.
|
Ohba, M.,
Shibanuma, M.,
Kuroki, T.,
and Nose, K.
(1994)
J. Cell Biol.
126,
1079-1088[Abstract/Free Full Text]
|
| 2.
|
Irani, K.,
Xia, Y.,
Zweier, J. L.,
Sollott, S. J.,
Der, C. J.,
Fearon, E. R.,
Sundaresan, M.,
Finkel, T.,
and Goldschimidt-Clermont, P. J.
(1997)
Science
275,
1649-1652[Abstract/Free Full Text]
|
| 3.
|
Nakamura, H.,
Nakamura, K.,
and Yodoi, J.
(1997)
Annu. Rev. Immunol.
15,
351-369[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Polyak, K.,
Xia, Y.,
Zweler, J. L.,
Kinzler, K. W.,
and Vogelstein, B.
(1997)
Nature
389,
300-305[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Saitoh, M.,
Nishitoh, H.,
Fujii, M.,
Takeda, K.,
Tobiume, K.,
Sawada, Y.,
Kawabata, M.,
Miyazono, K.,
and Ichijo, H.
(1998)
EMBO J.
17,
2596-2606[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Shaulian, E.,
and Karin, M.
(2001)
Oncogene
20,
2390-2400[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
van Dam, H.,
and Castellazzi, M.
(2001)
Oncogene
20,
2453-2464[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Kataoka, K.,
Noda, M.,
and Nishizawa, M.
(1994)
Mol. Cell. Biol.
14,
700-712[Abstract/Free Full Text]
|
| 9.
|
Kataoka, K.,
Igarashi, K.,
Itoh, K.,
Fujiwara, K. T.,
Noda, M.,
Yamamoto, M.,
and Nishizawa, M.
(1995)
Mol. Cell. Biol.
15,
2180-2190[Abstract]
|
| 10.
|
Andrews, N. C.,
Erdjument-Bromage, H.,
Davidson, M. B.,
Tempst, P.,
and Orkin, S. H.
(1993)
Nature
362,
722-728[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Chan, J. Y.,
Han, X.-L.,
and Kan, Y. W.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
11371-11375[Abstract/Free Full Text]
|
| 12.
|
Igarashi, K.,
Kataoka, K.,
Itoh, K.,
Hayashi, N.,
Nishizawa, M.,
and Yamamoto, M.
(1994)
Nature
367,
568-572[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Moi, P.,
Chan, K.,
Asunis, I.,
Cao, A.,
and Kan, Y. W.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
9926-9930[Abstract/Free Full Text]
|
| 14.
|
Toki, T.,
Itoh, J.,
Kitazawa, J.,
Arai, K.,
Hatakeyama, K.,
Akasaka, J.,
Igarashi, K.,
Nomura, N.,
Yokoyama, M.,
Yamamoto, M.,
and Ito, E.
(1997)
Oncogene
14,
1901-1910[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Kobayashi, A.,
Ito, E.,
Toki, T.,
Kogame, K.,
Takahashi, S.,
Igarashi, K.,
Hayashi, N.,
and Yamamoto, M.
(1999)
J. Biol. Chem.
274,
6443-6452[Abstract/Free Full Text]
|
| 16.
|
Oyake, T.,
Itoh, K.,
Motohashi, H.,
Hayashi, N.,
Hoshino, H.,
Nishizawa, M.,
Yamamoto, M.,
and Igarashi, K.
(1996)
Mol. Cell. Biol.
16,
6083-6095[Abstract]
|
| 17.
|
Igarashi, K.,
Itoh, K.,
Motohashi, H.,
Hayashi, N.,
Matuzaki, Y.,
Nakauchi, H.,
Nishizawa, M.,
and Yamamoto, M.
(1995)
J. Biol. Chem.
270,
7615-7624[Abstract/Free Full Text]
|
| 18.
|
Motohashi, H.,
Katsuoka, F.,
Shavit, J. A.,
Engel, J. D.,
and Yamamoto, M.
(2000)
Cell
103,
865-875[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Rushmore, T. H.,
King, R. G.,
Paulson, K. E.,
and Pickett, C. B.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
3826-3830[Abstract/Free Full Text]
|
| 20.
|
Friling, R. S.,
Bergelson, S.,
and Daniel, V.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
668-672[Abstract/Free Full Text]
|
| 21.
|
Wasserman, W. W.,
and Fahl, W. E.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
5361-5366[Abstract/Free Full Text]
|
| 22.
|
Itoh, K.,
Wakabayashi, N.,
Katoh, Y.,
Ishii, T.,
Igarashi, K.,
Engel, J. D.,
and Yamamoto, M.
(1999)
Genes Dev.
13,
76-86[Abstract/Free Full Text]
|
| 23.
|
Hoshino, H.,
Kobayashi, A.,
Yoshida, M.,
Kudo, N.,
Oyake, T.,
Motohashi, H.,
Hayashi, N.,
Yamamoto, M.,
and Igarashi, K.
(2000)
J. Biol. Chem.
275,
15370-15376[Abstract/Free Full Text]
|
| 24.
|
Itoh, K.,
Chiba, T.,
Takahashi, S.,
Ishii, T.,
Igarashi, K.,
Katoh, Y.,
Oyake, T.,
Hayashi, N.,
Satoh, K.,
Hatayama, I.,
Yamamoto, M.,
and Nabeshima, Y.
(1997)
Biochem. Biophys. Res. Commun.
236,
313-322[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Kwong, M.,
Kan, Y. W.,
and Chan, J. Y.
(1999)
J. Biol. Chem.
274,
37491-37498[Abstract/Free Full Text]
|
| 26.
|
Chan, J. Y.,
and Kwong, M.
(2000)
Biochem. Biophys. Res. Commun.
1517,
19-26
|
| 27.
|
Ishii, T.,
Itoh, K.,
Takahashi, S.,
Sato, H.,
Yanagawa, T.,
Katoh, Y.,
Bannai, S.,
and Yamamoto, M.
(2000)
J. Biol. Chem.
275,
16023-16029[Abstract/Free Full Text]
|
| 28.
|
Kume, A., Xu, R.,
Ueda, Y.,
Urabe, M.,
and Ozawa, K.
(2000)
Gene Ther.
7,
1193-1199[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Muto, A.,
Hoshino, H.,
Madisen, L.,
Yanai, N.,
Obinata, M.,
Karasuyama, H.,
Hayashi, N.,
Nakauchi, H.,
Yamamoto, M.,
Groudine, M.,
and Igarashi, K.
(1998)
EMBO J.
17,
5734-5743[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Kataoka, K.,
Handa, H.,
and Nishizawa, M.
(2001)
J. Biol. Chem.
276,
34074-34081[Abstract/Free Full Text]
|
| 31.
|
Sasaki, S.,
Ito, E.,
Toki, T.,
Maekawa, T.,
Kanezaki, R.,
Umenai, T.,
Muto, A.,
Nagai, H.,
Kinoshita, T.,
Yamamoto, M.,
Inazawa, J.,
Taketo, M. M.,
Nakahata, T.,
Igarashi, K.,
and Yokoyama, M.
(2000)
Oncogene
19,
3739-3749[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
International Human Genome Sequencing Consortium.
(2001)
Nature
409,
860-921[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Bardwell, V. J.,
and Treisman, R.
(1994)
Genes Dev.
8,
1664-1677[Abstract/Free Full Text]
|
| 34.
|
Dhordain, P.,
Albagli, O.,
Ansieau, S.,
Koken, M. H.,
Deweindt, C.,
Quief, S.,
Lantoine, D.,
Leutz, A.,
Kerckaert, J. P.,
and Leprince, D.
(1995)
Oncogene
11,
2689-2697[Medline]
[Order article via Infotrieve]
|
| 35.
|
Dong, S.,
Zhu, J.,
Reid, A.,
Strutt, P.,
Guidez, F.,
Zhong, H.-J.,
Wang, Z.-Y.,
Licht, J.,
Waxman, S.,
Chomienne, C.,
Chen, Z.,
Zelent, A.,
and Chen, S.-J.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
3624-3629[Abstract/Free Full Text]
|
| 36.
|
Igarashi, K.,
Hoshino, H.,
Muto, A.,
Suwabe, N.,
Nishikawa, S.,
Nakauchi, H.,
and Yamamoto, M.
(1998)
J. Biol. Chem.
273,
11783-11790[Abstract/Free Full Text]
|
| 37.
|
Yoshida, C.,
Tokumasu, F.,
Hohmura, K. I.,
Bungert, J.,
Hayashi, N.,
Nagasawa, T.,
Engel, J. D.,
Yamamoto, M.,
Takeyasu, K.,
and Igarashi, K.
(1999)
Genes Cells
4,
643-655[Abstract]
|
| 38.
|
Albalgi, O.,
Dhordain, P.,
Bernardin, F.,
Quief, S.,
Kerckaert, J. P.,
and Leprince, D.
(1996)
Biochem. Biophys. Res. Commun.
220,
911-915[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Nishizawa, M.,
Kataoka, K.,
Goto, N.,
Fujiwara, K. T.,
and Kawai, S.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
7711-7715[Abstract/Free Full Text]
|
| 40.
|
Kataoka, K.,
Nishizawa, M.,
and Kawai, S.
(1993)
J. Virol.
67,
2133-2141[Abstract/Free Full Text]
|
| 41.
|
Fujiwara, K. T.,
Kataoka, K.,
and Nishizawa, M.
(1993)
Oncogene
8,
2371-2380[Medline]
[Order article via Infotrieve]
|
| 42.
|
Vogt, P. K.
(2001)
Oncogene
20,
2365-2377[CrossRef][Medline]
[Order article via Infotrieve]
|
| 43.
|
Kataoka, K.,
Shioda, S.,
Yoshitomo-Nakagawa, K.,
Handa, H.,
and Nishizawa, M.
(2001)
J. Biol. Chem.
276,
36849-336856[Abstract/Free Full Text]
|
| 44.
|
Vigneri, P.,
and Wang, J. Y. J.
(2001)
Nat. Med.
7,
228-234[CrossRef][Medline]
[Order article via Infotrieve]
|
| 45.
|
Albalgi, O.,
Dhordain, P.,
Deweindt, C.,
Lecocq, G.,
and Leprince, D.
(1995)
Cell Growth Differ.
6,
1193-1198[Abstract]
|
| 46.
|
Dyck, J. A.,
Maul, G.,
Miller, W. H.,
Chen, J. D.,
Kakizuka, A.,
and Evans, R. M.
(1994)
Cell
76,
333-343[CrossRef][Medline]
[Order article via Infotrieve]
|
| 47.
|
Ishov, A.,
Sotnikov, A.,
Negorev, D.,
Vladimirova, O.,
Neff, N.,
Kamitani, T.,
Yeh, E.,
Strauss, J.,
and Maul, G.
(1999)
J. Cell Biol.
147,
221-223[Abstract/Free Full Text]
|
| 48.
|
Quignon, F., De,
Bels, F.,
Koken, M.,
Feunteun, J.,
Ameisen, J.-C.,
and de The, H.
(1998)
Nat. Genet.
20,
259-265[CrossRef][Medline]
[Order article via Infotrieve]
|
| 49.
|
Wang, Z.-G.,
Ruggero, D.,
Ronchetti, S.,
Zhong, S.,
Gaboli, M.,
Rivi, R.,
and Pandolfi, P. P.
(1998)
Nat. Genet.
20,
266-272[CrossRef][Medline]
[Order article via Infotrieve]
|
| 50.
|
Biguet, C.,
Wakasugi, N.,
Mishal, Z.,
Holmgren, A.,
Chouaib, S.,
Tursz, T.,
and Wakasugi, H.
(1994)
J. Biol. Chem.
269,
28865-28870[Abstract/Free Full Text]
|
| 51.
|
Alam, J.,
Stewart, D.,
Touchard, C.,
Boinapally, S.,
Choi, A. M.,
and Cook, J. L.
(2000)
J. Biol. Chem.
274,
26071-26078
|
| 52.
|
Sun, J.,
Muto, A.,
Hoshino, H.,
Kobayashi, A.,
Nishimura, S.,
Yamamoto, M.,
Hayashi, N.,
Ito, E.,
and Igarashi, K.
(2001)
J. Biochem. (Tokyo)
130,
385-392[Abstract/Free Full Text]
|
| 53.
|
Zhong, S.,
Salomoni, P.,
and Pandolfi, P. P.
(2000)
Nat. Cell Biol.
2,
E85-E90[CrossRef][Medline]
[Order arti |